The announcement this week that the BMJ will publish clinical trials only if the researchers have agreed to provide detailed patient level data when requested has been applauded by the drug firm...
Gilead Sciences filed with the FDA to market "boosting" agent cobicistat, which increases the blood level of some protease in -More- …
